Insulin Lispro Protamine And Insulin Lispro Injectable Suspension Injection, Suspension
Product Images NDC 0002-8233

Product Visual Gallery

This gallery contains 26 technical images submitted to the FDA as part of the official labeling for Insulin Lispro Protamine And Insulin Lispro Injectable Suspension (NDC 0002-8233). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eli Lilly And Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Il Mix75 Inj Site V1)

An anatomical illustration showing recommended subcutaneous injection sites for Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix 75/25 KwikPen. Shaded areas indicate suitable injection regions on the abdomen front and upper thighs front and back sides of the body.*

FDA Label Image

Il Mix75 Kp Carton 049 01

The packaging label for Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25 KwikPen by Eli Lilly and Company. It shows a mix of 75% insulin lispro protamine suspension and 25% insulin lispro, U-100 strength (100 units per mL). The label includes a depiction of the KwikPen device and states the package contains five 3 mL prefilled pens. The label notes it is for single patient use only, subcutaneous injection, and indicates needles are not included.*

FDA Label Image

Il Mix75 Kp Ifu 1 V2

Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix 75/25 KwikPen is a subcutaneous injection suspension with a strength of 100 units per mL. The pen is labeled for single-patient use and is manufactured by Eli Lilly and Company. The dose window shows a partial dose dialed on the pen.*

FDA Label Image

Il Mix75 Kp Ifu 10 V3

An illustration showing a dosing window with measurement markings from 0 to 4, accompanied by a large red arrow pointing upward. This likely depicts the adjustment mechanism for setting a dose on a pen injector device.*

FDA Label Image

Il Mix75 Kp Ifu 11 V2

An instructional illustration showing a hand holding an insulin pen with the other hand adjusting the dose knob. The image likely demonstrates how to set or dial the insulin dose on the pen injector for subcutaneous injection.*

FDA Label Image

Il Mix75 Kp Ifu 12 V3

An instructional illustration showing hands holding an Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix 75/25 KwikPen. The image highlights the pen tip with a close-up view of a droplet at the needle tip, indicating liquid presence. A red arrow points upward from the pen cap, suggesting a step in preparing the injection device.*

FDA Label Image

Il Mix75 Kp Ifu 13 V3

An illustration showing the dosage window of a KwikPen injector displaying insulin units. The example shows the dose dial set at 10 units on the pen's dosage selector.*

FDA Label Image

Il Mix75 Kp Ifu 14 V3

An instructional illustration showing a close-up of a hand holding a KwikPen injector. The view focuses on the dose selector window displaying dose numbers 8 and 10, with a red arrow indicating an upward motion on the pen's dose knob.*

FDA Label Image

Il Mix75 Kp Ifu 15 V3

An instructional diagram showing the dose window of a KwikPen injector displaying a dosage setting of 12 units, with a red arrow pointing to the number for emphasis. The pen is shown in blue and white colors, illustrating the dose selection feature for subcutaneous injection.*

FDA Label Image

Il Mix75 Kp Ifu 16 V3

An illustration showing a close-up view of a dosing window on a pen injector for Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix 75/25 KwikPen. The dial displays dose numbers, highlighting a dose of 26 units with an indicator arrow pointing to the number.*

FDA Label Image

Il Mix75 Kp Ifu 17 V2

An instructional illustration showing the proper technique for injecting insulin subcutaneously into the abdomen. It depicts a hand holding a KwikPen injector at a 90-degree angle to the skin, targeting the area just above the waistband of pants.*

FDA Label Image

Il Mix75 Kp Ifu 19 V3

An instructional illustration showing a hand holding an injection pen device and removing the cap by pulling it off, indicated by a red arrow pointing away from the pen.*

FDA Label Image

Il Mix75 Kp Ifu 2 V2

An exploded diagram of the Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix 75/25 KwikPen shows its main components. Labeled parts include the pen cap with cap clip, rubber seal, cartridge holder containing the insulin cartridge, plunger, pen body with product label, dose window, dose indicator, and dose knob. The pen is designed for subcutaneous injection.*

FDA Label Image

Il Mix75 Kp Ifu 20 V3

An instructional illustration showing a hand holding an insulin pen labeled for subcutaneous injection. The pen's dosing scale is visible, indicating units of insulin to be administered. The image includes an arrow wrapped around the pen, suggesting a twisting or mixing action prior to use.*

FDA Label Image

Il Mix75 Kp Ifu 21 V3

An instructional illustration showing a blue Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix 75/25 KwikPen. The pen is shown horizontally with an arrow pointing to the left, indicating the direction for possibly removing or preparing the pen for injection.*

FDA Label Image

Figure (Il Mix75 Kp Ifu 3 V1)

An instructional diagram showing the parts of a pen needle assembly for injection devices. It labels the Outer Needle Shield, Inner Needle Shield, Needle, and Paper Tab, noting that needles are not included. This illustration is related to the use of injectable insulin products.*

FDA Label Image

Il Mix75 Kp Ifu 4 V2

An instructional diagram showing the removal of the blue cap from the Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix 75/25 KwikPen.*

FDA Label Image

Il Mix75 Kp Ifu 5 V3

An instructional illustration showing a hand holding an insulin pen, with arrows indicating a shaking or mixing motion. This diagram likely demonstrates how to mix the Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix 75/25 prior to use.*

FDA Label Image

Il Mix75 Kp Ifu 6 V3

An instructional illustration showing how to hold and rotate the insulin pen device for the Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix 75/25 KwikPen. The image depicts a hand gripping the pen and arrows indicating a rotational movement of the pen at different angles.*

FDA Label Image

Figure (Il Mix75 Kp Ifu 7 V1)

An instructional illustration showing a hand twisting a cap or protective covering off a small vial or pen device, indicated by a red curved arrow pointing upward. The image likely demonstrates preparing the device for use, relevant to subcutaneous injectable medications.*

FDA Label Image

Figure (Il Mix75 Kp Ifu 8 V1)

An instructional diagram showing how to remove the protective outer cap from a pen injector. The image features a pen with an arrow indicating a twisting motion to detach the cap from the device nozzle.*

FDA Label Image

Figure (Il Mix75 Kp Ifu 9 V1)

An instructional illustration showing the proper handling of needle shields for an injection pen. It advises to keep the outer needle shield and to throw away the inner needle shield.*

FDA Label Image

Figure (Il Mix75 Kp Ifu Clock V1)

An illustration of a stopwatch set to 5 seconds, indicating a brief timed interval. The stopwatch is depicted with a circular dial and the number "5 sec" centered within it.*

FDA Label Image

Figure 1 (Il Mix75 Uspi 1 V1)

A line graph showing the glucose infusion rate (mg/min/kg) over time (hours) for different insulin formulations including Humalog U-100, Humalog Mix50/50, Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix75/25, and a labeled series ILPS. The graph compares their glucose infusion rates up to 24 hours post-administration.*

FDA Label Image

Figure 2 (Il Mix75 Uspi 2 V1)

A line graph comparing glucose infusion rate (mg/min/kg) over 12 hours for Insulin Lispro Protamine and Insulin Lispro Injectable Suspension Mix 75/25 versus Humulin 70/30, both at 0.3 U/kg. The graph shows two curves representing the glucose infusion rate profiles of each insulin preparation over time.*

FDA Label Image

Primary Structure (Il Mix75 Uspi Chem V1)

Chemical structure diagram illustrating the amino acid sequences of the A-chain and B-chain of insulin lispro, showing the specific order and connections between amino acids in the peptide chains.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.